We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-4.67%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$268M
AUM Growth
-$87.1M
Cap. Flow
-$62.9M
Cap. Flow %
-23.5%
Top 10 Hldgs %
61.83%
Holding
30
New
2
Increased
4
Reduced
22
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.3M
2
AMGN icon
Amgen
AMGN
+$8.81M
3
ABT icon
Abbott
ABT
+$7.42M
4
CNC icon
Centene
CNC
+$1.66M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.63M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$12.1M
2
PFE icon
Pfizer
PFE
+$9.48M
3
CAH icon
Cardinal Health
CAH
+$7.69M
4
UHS icon
Universal Health Services
UHS
+$6.17M
5
GMED icon
Globus Medical
GMED
+$5.65M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
26
Centene
CNC
$32.5B
$2.98M 1.11%
45,000
+22,784
+103% +$1.66M
LNTH icon
27
Lantheus
LNTH
$6.8B
$2.55M 0.95%
31,712
-21,348
-40% -$1.57M
VTRS icon
28
Viatris
VTRS
$19.8B
$1.1M 0.41%
103,106
-314,551
-75% -$3.48M
GMED icon
29
Globus Medical
GMED
$10.3B
-105,381
Closed -$5.65M
ILMN icon
30
Illumina
ILMN
$27.9B
-17,476
Closed -$2.33M

Similar funds

Sector Gamma AS's Q2 2024 Portfolio in Review

As of Q2 2024, Sector Gamma AS held 30 positions worth $268M, down 25% from $355M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sector Gamma AS withdrew a net $62.9M in Q2 2024, closing 2 positions and reducing 22 holdings. Its most notable exit was Globus Medical, an estimated $5.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Amgen worth $9.37M.

  • Sector Gamma AS's largest Q2 2024 buy was Amgen: 30,000 shares worth $9.37M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2024, an estimated $10.3M increase.
  • Sector Gamma AS's biggest Q2 2024 reduction was Medtronic, cutting an estimated $12.1M.
  • Sector Gamma AS fully exited Globus Medical in Q2 2024, selling an estimated $5.65M.
  • Sector Gamma AS's ten largest holdings make up 62% of its $268M portfolio in Q2 2024.
  • Sector Gamma AS opened 2 new positions and closed 2 in Q2 2024.
  • Sector Gamma AS's portfolio value fell 25% quarter-over-quarter to $268M.

Based on Sector Gamma AS's 13F filing for Q2 2024, filed 9 Aug 2024.